Vittoria Maresca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vittoria Maresca has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Mauro Picardo
Immaculate Institute of Dermatopathology and Scientific Institute of Recovery, Hospitalisation and Cure (IDI-IRCCS), Rome, Italy
17 shared publications - Enrica Flori
Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy
13 shared publications - Stefania Briganti
San Gallicano Dermatological Institute IRCCS, Rome, Italy
6 shared publications - Barbara Bellei
Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy
5 shared publications - Giorgia Cardinali
Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy
5 shared publications - Emanuela Camera
Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy
4 shared publications
Latest Publications
- Open Access
- 21 April 2021
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 34 (4) , 748-761
The α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation
Melanocortin‐1 Receptor (MC1R), when stimulated by alpha‐melanocyte‐stimulating hormone (α‐MSH), is a driver of eumelanogenesis. Brown/black eumelanin is an effective filter against ultraviolet radiation (UVR) and is a scavenger of free radicals. Several polymorphic variants of MC1R are frequent in red‐head people. These polymorphisms reduce the ability of MC1R to promote eumelanogenesis after its activation and spontaneous pheomelanogenesis take place. Since pheomelanin can act as an endogenous photosensitizer, people carrying MC1R polymorphisms are more susceptible to skin cancer. Here, we summarize current knowledge on the biology of MC1R beyond its ability to drive eumelanogenesis. We analyze its capacity to cope with oxidative insult and consequent DNA damage. We describe its ability to transduce through different pathways. We start from the canonical pathway, the cAMP/protein kinase A (PKA) pathway mainly involved in promoting eumelanogenesis, and protection from oxidative damage, and we then move on to describe more recent knowledge concerning ERK pathways, phosphoinositide 3‐kinase (PI3K) pathway/AKT, and α‐MSH/Peroxisome proliferators activated receptor‐γ (PPAR‐γ) connection. We describe MC1R polymorphic variants associated with melanoma risk which represent an open window of clinical relevance.
- 21 April 2021
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 34 (4) , 748-761
Open AccessThe α‐melanocyte‐stimulating hormone/melanocortin‐1 receptor interaction: A driver of pleiotropic effects beyond pigmentation
Melanocortin‐1 Receptor (MC1R), when stimulated by alpha‐melanocyte‐stimulating hormone (α‐MSH), is a driver of eumelanogenesis. Brown/black eumelanin is an effective filter against ultraviolet radiation (UVR) and is a scavenger of free radicals. Several polymorphic variants of MC1R are frequent in red‐head people. These polymorphisms reduce the ability of MC1R to promote eumelanogenesis after its activation and spontaneous pheomelanogenesis take place. Since pheomelanin can act as an endogenous photosensitizer, people carrying MC1R polymorphisms are more susceptible to skin cancer. Here, we summarize current knowledge on the biology of MC1R beyond its ability to drive eumelanogenesis. We analyze its capacity to cope with oxidative insult and consequent DNA damage. We describe its ability to transduce through different pathways. We start from the canonical pathway, the cAMP/protein kinase A (PKA) pathway mainly involved in promoting eumelanogenesis, and protection from oxidative damage, and we then move on to describe more recent knowledge concerning ERK pathways, phosphoinositide 3‐kinase (PI3K) pathway/AKT, and α‐MSH/Peroxisome proliferators activated receptor‐γ (PPAR‐γ) connection. We describe MC1R polymorphic variants associated with melanoma risk which represent an open window of clinical relevance.
- 30 June 2020
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 34 (1) , 72-88
The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment
The Melanocortin‐1 receptor (MC1R) belongs to the family of the G protein Coupled Receptor (GPCR). Activated GPCRs can promote the phosphoinositide 3‐kinase (PI3K) pathway. Few studies deal with the role of the PI3K‐pathway activation in response to αMSH. On B16‐F10 cell line, we investigated the αMSH‐dependent modulation of pAKT/AKT, as a key element of the PI3K pathway after rapid and prolonged stimulation. We demonstrated that αMSH triggers a rapid modulation of AKT which culminates in an increase in its phosphorylation. We highlighted a comparable up‐regulation of pAKT after exposure to αMSH on primary cultures of normal human melanocytes (NHMs) expressing a wild type MC1R. On B16‐F10 cells, NHMs and an ex‐vivo model of human skin biopsies, we explored the influence of PI3K/AKT signaling triggered by αMSH, focusing on the control of melanogenesis and pigment release. We showed that the αMSH‐dependent PI3K/AKT pathway exerts a negative feedback on melanogenesis and promotes the extracellular release of pigment. We strengthened the role of the PI3K/AKT pathway triggered by αMSH in preserving redox equilibrium and genome integrity, highlighting its role in affecting cell survival.
- 30 June 2020
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 34 (1) , 72-88
The PI3K pathway induced by αMSH exerts a negative feedback on melanogenesis and contributes to the release of pigment
The Melanocortin‐1 receptor (MC1R) belongs to the family of the G protein Coupled Receptor (GPCR). Activated GPCRs can promote the phosphoinositide 3‐kinase (PI3K) pathway. Few studies deal with the role of the PI3K‐pathway activation in response to αMSH. On B16‐F10 cell line, we investigated the αMSH‐dependent modulation of pAKT/AKT, as a key element of the PI3K pathway after rapid and prolonged stimulation. We demonstrated that αMSH triggers a rapid modulation of AKT which culminates in an increase in its phosphorylation. We highlighted a comparable up‐regulation of pAKT after exposure to αMSH on primary cultures of normal human melanocytes (NHMs) expressing a wild type MC1R. On B16‐F10 cells, NHMs and an ex‐vivo model of human skin biopsies, we explored the influence of PI3K/AKT signaling triggered by αMSH, focusing on the control of melanogenesis and pigment release. We showed that the αMSH‐dependent PI3K/AKT pathway exerts a negative feedback on melanogenesis and promotes the extracellular release of pigment. We strengthened the role of the PI3K/AKT pathway triggered by αMSH in preserving redox equilibrium and genome integrity, highlighting its role in affecting cell survival.
- Open Access
- 11 October 2017
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 36 (1) , 142
The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines
The α-Melanocyte Stimulating Hormone (αMSH)/Melanocortin-1 receptor (MC1R) interaction promotes melanogenesis through the cAMP/PKA pathway. The direct induction of this pathway by Forskolin (FSK) is also known to enhance melanocyte proliferation. αMSH acts as a mitogenic agent in melanocytes and its effect on proliferation of melanoma cells is less known. We previously identified the αMSH/Peroxisome Proliferator Activated Receptor (PPARγ) pathway as a new pathway on the B16-F10 mouse melanoma cell line. αMSH induced the translocation of PPARγ into the nucleus as an active transcription factor. This effect was independent of the cAMP/PKA pathway and was mediated by the activation of the PI(4,5)P2/PLC pathway, a pathway which we have described to be triggered by the αMSH-dependent MC1R stimulation. Moreover, in the same study, preliminary experiments showed that mouse melanoma cells responded to αMSH by reducing proliferation and that PPARγ was involved in this effect. Due to its key role in the control of cell proliferation, PPARγ agonists are used in therapeutic models for different forms of cancer, including melanoma. The purpose of this study was: (a) to confirm the different proliferative behavior in response to αMSH in healthy and in melanoma condition; (b) to verify whether the cAMP/PKA pathway and the PLC/PPARγ pathway could exert an antagonistic function in the control of proliferation; (c) to deepen the knowledge of the molecular basis responsible for the down-proliferative response of melanoma cells after exposure to αMSH. We employed B16-F10 cell line, a human melanoma cell line (Mel 13) and two primary cultures of human melanocytes (NHM 1 and NHM 2, respectively), all expressing a wild type MC1R and responding to the αMSH in terms of pigmentation. We evaluated cell proliferation through: a) cell counting, b) cell cycle analysis c) protein expression of proliferation modulators (p27, p21, cyclin D1 and cyclin E). The αMSH acted as a mitogenic agent in primary cultures of human melanocytes, whereas it determined a slow down of proliferation in melanoma cell lines. FSK, as an inducer of the cAMP/PKA pathway, reproduced the αMSH mediated effect on proliferation in NHMs but it did not mimic the αMSH effect on proliferation in B16-F10 and Mel 13 melanoma cell lines. Meanwhile, 3 M3-FBS (3 M3), as an inducer of PI(4,5)P2/PLC pathway, reproduced the αMSH proliferative effect. Further experiments, treating melanoma cell lines with αMSH in the presence/absence of GW9662, as an inhibitor of PPARγ, confirmed the key role of this transcription factor in decreasing cell proliferation in response to the hormone exposure. In both melanoma cell lines, αMSH determined the reduction of proliferation through the PI(4,5)P2/PLC pathway, employing PPARγ as an effector element. These evidence could offer perspectives for new therapeutic approaches for melanoma.
- 11 October 2017
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 36 (1) , 142
Open AccessThe α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines
The α-Melanocyte Stimulating Hormone (αMSH)/Melanocortin-1 receptor (MC1R) interaction promotes melanogenesis through the cAMP/PKA pathway. The direct induction of this pathway by Forskolin (FSK) is also known to enhance melanocyte proliferation. αMSH acts as a mitogenic agent in melanocytes and its effect on proliferation of melanoma cells is less known. We previously identified the αMSH/Peroxisome Proliferator Activated Receptor (PPARγ) pathway as a new pathway on the B16-F10 mouse melanoma cell line. αMSH induced the translocation of PPARγ into the nucleus as an active transcription factor. This effect was independent of the cAMP/PKA pathway and was mediated by the activation of the PI(4,5)P2/PLC pathway, a pathway which we have described to be triggered by the αMSH-dependent MC1R stimulation. Moreover, in the same study, preliminary experiments showed that mouse melanoma cells responded to αMSH by reducing proliferation and that PPARγ was involved in this effect. Due to its key role in the control of cell proliferation, PPARγ agonists are used in therapeutic models for different forms of cancer, including melanoma. The purpose of this study was: (a) to confirm the different proliferative behavior in response to αMSH in healthy and in melanoma condition; (b) to verify whether the cAMP/PKA pathway and the PLC/PPARγ pathway could exert an antagonistic function in the control of proliferation; (c) to deepen the knowledge of the molecular basis responsible for the down-proliferative response of melanoma cells after exposure to αMSH. We employed B16-F10 cell line, a human melanoma cell line (Mel 13) and two primary cultures of human melanocytes (NHM 1 and NHM 2, respectively), all expressing a wild type MC1R and responding to the αMSH in terms of pigmentation. We evaluated cell proliferation through: a) cell counting, b) cell cycle analysis c) protein expression of proliferation modulators (p27, p21, cyclin D1 and cyclin E). The αMSH acted as a mitogenic agent in primary cultures of human melanocytes, whereas it determined a slow down of proliferation in melanoma cell lines. FSK, as an inducer of the cAMP/PKA pathway, reproduced the αMSH mediated effect on proliferation in NHMs but it did not mimic the αMSH effect on proliferation in B16-F10 and Mel 13 melanoma cell lines. Meanwhile, 3 M3-FBS (3 M3), as an inducer of PI(4,5)P2/PLC pathway, reproduced the αMSH proliferative effect. Further experiments, treating melanoma cell lines with αMSH in the presence/absence of GW9662, as an inhibitor of PPARγ, confirmed the key role of this transcription factor in decreasing cell proliferation in response to the hormone exposure. In both melanoma cell lines, αMSH determined the reduction of proliferation through the PI(4,5)P2/PLC pathway, employing PPARγ as an effector element. These evidence could offer perspectives for new therapeutic approaches for melanoma.
- Open Access
- 18 March 2015
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 28 (4) , 378-389
Skin phototype: a new perspective
Summary: Cutaneous phototype is considered mainly related to cutaneous pigmentation and to the eumelanin/pheomelanin ratio, which is mostly genetically determined by the melanocortin 1 receptor (MC1R) polymorphisms. However, data in literature indicate that, in addition to stimulation of eumelanin synthesis, the MC1R signalling activates antioxidant, DNA repair and survival pathways. New emerging aspects regarding photoprotection and skin phototypes are going beyond those features connected to the melanin content in the skin. Important new findings link the MC1R to nuclear receptors activation, shedding light on new extra‐melanogenic effects dependent on the α‐melanocyte‐stimulating hormone (α‐MSH) activity and new ways through which such functions are modulated. These evidences indicate that several factors including melanin play a part in defining the basis for individual sun sensitivity, suggesting that the cutaneous phototype represents a ‘biochemical fingerprint’.
- 18 March 2015
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 28 (4) , 378-389
Open AccessSkin phototype: a new perspective
Summary: Cutaneous phototype is considered mainly related to cutaneous pigmentation and to the eumelanin/pheomelanin ratio, which is mostly genetically determined by the melanocortin 1 receptor (MC1R) polymorphisms. However, data in literature indicate that, in addition to stimulation of eumelanin synthesis, the MC1R signalling activates antioxidant, DNA repair and survival pathways. New emerging aspects regarding photoprotection and skin phototypes are going beyond those features connected to the melanin content in the skin. Important new findings link the MC1R to nuclear receptors activation, shedding light on new extra‐melanogenic effects dependent on the α‐melanocyte‐stimulating hormone (α‐MSH) activity and new ways through which such functions are modulated. These evidences indicate that several factors including melanin play a part in defining the basis for individual sun sensitivity, suggesting that the cutaneous phototype represents a ‘biochemical fingerprint’.
- 2 August 2012
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 26 (1) , 113-127
Linking αMSH with PPARγ in B16‐F10 melanoma
Summary: We have discovered a new α‐melanocyte stimulating hormone (α‐MSH)/peroxisome proliferator activated receptor‐γ (PPAR‐γ) connection in B16‐F10 cells. Both PPAR‐γ up‐regulation and its induction as an active transcription factor were observed in response to α‐MSH. The α‐MSH/PPAR‐γ connection influenced both pigmentation and proliferation. The forskolin‐stimulated cAMP/PKA pathway was not able to induce either PPAR‐γ translocation into the nucleus or PPAR‐γ transcriptional activity. As the melanocortin‐1 receptor, the specific receptor for the α‐MSH, is a G‐protein coupled receptor, we wondered whether the phosphatidylinositol [PI(4,5)P2/PLCβ] signal pathway was involved in mediating the α‐MSH‐dependent PPAR‐γ activation. Employing inhibitors of PI(4,5)P2/PLCβ pathway, the results of our experiments suggested that this pathway was promoted by α‐MSH and that α‐MSH played a role in mediating PPAR‐γ activation. We have demonstrated, for the first time, that α‐MSH induces the PI(4,5)P2/PLCβ pathway, through analysis of the basic steps of the pathway. The α‐MSH effect on PPAR‐γ was independent of animal species and was not correlated with the physio‐pathological status.
- 2 August 2012
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 26 (1) , 113-127
Linking αMSH with PPARγ in B16‐F10 melanoma
Summary: We have discovered a new α‐melanocyte stimulating hormone (α‐MSH)/peroxisome proliferator activated receptor‐γ (PPAR‐γ) connection in B16‐F10 cells. Both PPAR‐γ up‐regulation and its induction as an active transcription factor were observed in response to α‐MSH. The α‐MSH/PPAR‐γ connection influenced both pigmentation and proliferation. The forskolin‐stimulated cAMP/PKA pathway was not able to induce either PPAR‐γ translocation into the nucleus or PPAR‐γ transcriptional activity. As the melanocortin‐1 receptor, the specific receptor for the α‐MSH, is a G‐protein coupled receptor, we wondered whether the phosphatidylinositol [PI(4,5)P2/PLCβ] signal pathway was involved in mediating the α‐MSH‐dependent PPAR‐γ activation. Employing inhibitors of PI(4,5)P2/PLCβ pathway, the results of our experiments suggested that this pathway was promoted by α‐MSH and that α‐MSH played a role in mediating PPAR‐γ activation. We have demonstrated, for the first time, that α‐MSH induces the PI(4,5)P2/PLCβ pathway, through analysis of the basic steps of the pathway. The α‐MSH effect on PPAR‐γ was independent of animal species and was not correlated with the physio‐pathological status.
- 1 April 2012
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (4) , 1196-1205
The Eumelanin Intermediate 5,6-Dihydroxyindole-2-Carboxylic Acid Is a Messenger in the Cross-Talk among Epidermal Cells
- 1 April 2012
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (4) , 1196-1205
The Eumelanin Intermediate 5,6-Dihydroxyindole-2-Carboxylic Acid Is a Messenger in the Cross-Talk among Epidermal Cells
- Open Access
- 1 March 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (10) , 7288-7299
p38 Regulates Pigmentation via Proteasomal Degradation of Tyrosinase
- 1 March 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (10) , 7288-7299
Open Accessp38 Regulates Pigmentation via Proteasomal Degradation of Tyrosinase
- Open Access
- 12 January 2010
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 23 (2) , 263-275
MC1R stimulation by α-MSH induces catalase and promotes its re-distribution to the cell periphery and dendrites
We demonstrated a direct correlation between melanogenic and catalase activities on in vitro and ex vivo models. Here, we investigated whether the stimulation of Melanocortin‐1 Receptor (MC1R) could influence catalase expression, activity and cellular localization. For this purpose, we treated B16‐F0 melanoma cells with α‐Melanocyte Stimulating Hormone (α‐MSH) and we showed a rapid induction of catalase through a cAMP/PKA‐dependent, microphthalmia‐associated transcription factor (MITF) independent mechanism, acting at post‐transcriptional level. Moreover, α‐MSH promoted a partial re‐distribution of catalase to the cell periphery and dendrites. This work strengthens the correlation between melanogenesis and anti‐oxidants, demonstrating the induction of catalase in response to a melanogenic stimulation, such as α‐MSH‐dependent MC1R activation. Moreover, this study highlights catalase regulatory mechanisms poorly known, and attributes to α‐MSH a protective role in defending melanocytes, and possibly keratinocytes, not only on the basis of its pigmentary action, but also for its capacity to stimulate a quick anti‐oxidant defence.
- 12 January 2010
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 23 (2) , 263-275
Open AccessMC1R stimulation by α-MSH induces catalase and promotes its re-distribution to the cell periphery and dendrites
We demonstrated a direct correlation between melanogenic and catalase activities on in vitro and ex vivo models. Here, we investigated whether the stimulation of Melanocortin‐1 Receptor (MC1R) could influence catalase expression, activity and cellular localization. For this purpose, we treated B16‐F0 melanoma cells with α‐Melanocyte Stimulating Hormone (α‐MSH) and we showed a rapid induction of catalase through a cAMP/PKA‐dependent, microphthalmia‐associated transcription factor (MITF) independent mechanism, acting at post‐transcriptional level. Moreover, α‐MSH promoted a partial re‐distribution of catalase to the cell periphery and dendrites. This work strengthens the correlation between melanogenesis and anti‐oxidants, demonstrating the induction of catalase in response to a melanogenic stimulation, such as α‐MSH‐dependent MC1R activation. Moreover, this study highlights catalase regulatory mechanisms poorly known, and attributes to α‐MSH a protective role in defending melanocytes, and possibly keratinocytes, not only on the basis of its pigmentary action, but also for its capacity to stimulate a quick anti‐oxidant defence.
- 1 December 2009
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 19 (6) , 372-378
Acidic catalase in human skin in vivo: a new marker of permanent damage
Malignant melanoma incidence is increasing rapidly in Western countries. Its prevention requires a deep knowledge of the biological basis of the neoplasm leading to the identification of new biological risk markers. In in-vitro and ex-vivo models we demonstrated that catalase was modified not only in its activity but also in its charge properties after ultraviolet A irradiation through pheomelanin. Here we focus on the electrophoretic behaviour of catalase in the human skin in vivo, in association with cutaneous phototype. Zymographic analysis of the enzyme on skin biopsies from Caucasian population (phototype I–IV), collected from the trunk in autumn–winter, to exclude possible influences of an acute photoexposure, evidenced a protein doublet, representing the coexistence of two active isoforms of catalase with different charge properties. In the skin from low-phototype subjects, the percent contribution of the more acidic component of the doublet was prevalent, inversely correlated with total melanin concentration in hair, and associated with a high number of melanocytic nevi. In summary, this study shows for the first time the existence of an acidic catalase in association with clinically defined risk characteristics in low phototype skin in vivo, contributing to the knowledge of a new biochemical marker of cutaneous photosusceptibility.
- 1 December 2009
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 19 (6) , 372-378
Acidic catalase in human skin in vivo: a new marker of permanent damage
Malignant melanoma incidence is increasing rapidly in Western countries. Its prevention requires a deep knowledge of the biological basis of the neoplasm leading to the identification of new biological risk markers. In in-vitro and ex-vivo models we demonstrated that catalase was modified not only in its activity but also in its charge properties after ultraviolet A irradiation through pheomelanin. Here we focus on the electrophoretic behaviour of catalase in the human skin in vivo, in association with cutaneous phototype. Zymographic analysis of the enzyme on skin biopsies from Caucasian population (phototype I–IV), collected from the trunk in autumn–winter, to exclude possible influences of an acute photoexposure, evidenced a protein doublet, representing the coexistence of two active isoforms of catalase with different charge properties. In the skin from low-phototype subjects, the percent contribution of the more acidic component of the doublet was prevalent, inversely correlated with total melanin concentration in hair, and associated with a high number of melanocytic nevi. In summary, this study shows for the first time the existence of an acidic catalase in association with clinically defined risk characteristics in low phototype skin in vivo, contributing to the knowledge of a new biochemical marker of cutaneous photosusceptibility.
- 1 October 2008
- Published by Elsevier in Cellular Signalling
- Vol. 20 (10) , 1750-1761
GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes
- 1 October 2008
- Published by Elsevier in Cellular Signalling
- Vol. 20 (10) , 1750-1761
GSK3β inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes